Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flupentixol-Melitracen Add-on Therapy in Functional Dyspepsia
TCTR20260325001Phase 3Active, not recruiting
- Sponsor
- Faculty of Medicine, Khon Kaen University
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in functional dyspepsia (FD) comparing Flupentixol-Melitracen add-on with Placebo add-on (2 arms). Started Mar 2026; status: active, not recruiting.
02
Drugs
flupentixol + melitracen
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on TCTR20260325001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260325001.